BioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.
Sign up today and learn more about BioTheryX Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About BioTheryX Stock
BioTheryX focuses on the development of therapies for hematological malignancies. It intends to leverage its extensive experience and proven commercial success to deliver efficacious therapies to patients with unmet medical needs more quickly and less expensively than the biomedical industry traditionally can and does. To do so, they are exploiting enhanced biology-driven models to identify effective core molecules that can be rapidly exploited using focused and prioritized chemistry approaches coupled with clinically proven translational approaches targeted for cancer and immune dysfunction. The company was founded in 2007 and is headquartered in Chappaqua, New York.
Chief Business Officer
Chief Financial Officer
Co-Founder, President & Board Member
Co-Founder, Chief Development Officer & Chairman & Owner
Chief Executive Officer